15 recruiting, 8 completed, 8 not yet recruiting, 2 active not recruiting. 7 Not applicable, 7 Phase 4, 2 Phase 1, 1 Phase 2, 1 Phase 3.
Follow Psoriatic Arthritis (PsA): new trials by email Literature Review of Psoriatic Arthritis (PsA) trials Research Report on Psoriatic Arthritis (PsA)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Trial of FT2109 for the Treatment of Psoriatic Arthritis FT2109 Dosing Regimen 1, FT2109 Dosing Regimen 2, Matching Placebo - Psoriatic Arthritis (PsA) | Phase 2 | Not yet recruiting | Forward Therapeutics | 210 | 2026-12-01 | 2026-10-09 |
| A Clinical Trial of Antiplatelets in Psoriasis Aspirin, Clopidogrel, Placebo - Psoriasis (PsO), Psoriatic Arthritis (PsA) | Phase 4 | Not yet recruiting | NYU Langone Health | 60 | 2026-09-01 | 2026-08-05 |
| Prevention of Psoriatic Arthritis Inflammation Through Digital Care: A Feasibility Mixed-Methods Study iPROLEPSIS Digital Health Ecossystem - Psoriatic Arthritis (PsA) | Not applicable | Not yet recruiting | Sociedade Portuguesa de Reumatologia | 72 | 2026-09-01 | 2026-09-16 |
| Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease Deucravacitinib, Placebo - Psoriatic Arthritis (PsA) | Phase 4 | Recruiting | University of Texas Southwestern Medical Center | 128 | 2026-06-16 | 2026-09-01 |
| Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease S-4321 - Autoimmune Diseases, Rheumatoid Arthritis (RA) | Phase 1 | Recruiting | Seismic Therapeutic AU Pty Ltd | 24 | 2026-06-01 | 2026-06-01 |
| Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial GLP-1 agonists, Nutrition Counseling - Psoriatic Arthritis (PsA) | Phase 4 | Recruiting | Medical College of Wisconsin | 22 | 2026-05-01 | 2026-08-10 |
| Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER) Carotid Ultrasound, High-intensity lipid-lowering therapy, Standard care according to ESC 2021 guidelines - Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) | Phase 4 | Recruiting | Instituto de Investigación Marqués de Valdecilla | 1944 | 2026-04-22 | 2026-05-28 |
| Preventing Structural Damage in Early Psoriatic Arthritis Amgevita 40Mg Solution for Injection, Methotrexate (Metoject® prefilled pen) - Psoriatic Arthritis (PsA) | Phase 4 | Recruiting | Chinese University of Hong Kong | 108 | 2026-03-16 | 2026-03-23 |
| Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases Dengue 1,2,3,4 (attenuated) vaccine - Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA) | Phase 4 | Recruiting | University of Sao Paulo General Hospital | 477 | 2026-03-16 | 2026-07-20 |
| Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis Ixekizumab, Tirzepatide - Psoriatic Arthritis (PsA), Obesity & Overweight | Not applicable | Recruiting | NHS Greater Glasgow and Clyde | 45 | 2026-03-09 | 2026-05-04 |
| Efficacy of a Self-Management Smartphone App to Improve Safety Skills in Patients With Inflammatory Arthritis SFR application - Rhumatoid Arthisis, Spondyloarthritis (SA) | Not applicable | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 144 | 2026-03-01 | 2026-03-13 |
| Oxidative Stress in Autoimmune Rheumatic Diseases Inflammatory Joint Diseases, Rheumatoid Arthritis (RA) | Recruiting | University of Thessaly | 200 | 2025-10-06 | 2026-04-28 | |
| Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis Psoriasis (PsO), Psoriatic Arthritis (PsA) | Recruiting | Charite University, Berlin, Germany | 500 | 2025-09-22 | 2025-12-23 | |
| REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases JAKi dose reduction strategy, JAKi disease activity guided continuation of same dose strategy - Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) | Phase 4 | Recruiting | Sint Maartenskliniek | 200 | 2025-09-15 | 2025-09-17 |
| Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor observational study - Axial Spondylarthritis (axSpA), Psoriatic Arthritis (PsA) | Recruiting | Adelphi Real World | 700 | 2025-07-07 | 2026-10-27 | |
| Personalized Outreach for Equitable Treatment in Rheumatology Honoraria, Outreach - Rheumatic Diseases, Inflammatory Arthritis | Not applicable | Not yet recruiting | University of British Columbia | 20 | 2025-07-02 | 2025-07-04 |
| Right Ventricular Strain in Detecting Subclinical Right Ventricular Systolic Dysfunction in Psoriatic Arthritis Patients: Relation to Serum Endostatin Level Psoriatic Arthritis (PsA), Subclinical Right Ventricular Systolic Dysfunction | Not yet recruiting | Ain Shams University | 60 | 2025-07-01 | 2025-07-01 | |
| Mass Spectrometry-based Immune Profiling in Autoimmune Diseases Systemic Lupus Erthematosus, Sjogren's Syndrome | Enrolling by invitation | Peking University People's Hospital | 500 | 2025-05-25 | 2026-08-26 | |
| A Randomized, Double-blind Clinical Trial on the Efficacy of a Dietary Formulation Containing Medium-chain Triglycerides (MCT) and Fiber in Patients With Psoriatic Arthritis MCTs and fiber, Placebo powder - Psoriatic Arthritis (PsA) | Not applicable | Completed | Dr. Schär AG / SPA | 72 | 2025-05-16 | 2026-04-20 |
| Comparison of Liver Health in Psoriatic Arthritis Patients Using Anti-TNF or Anti-IL17 Treatments Psoriatic Arthritis (PsA), Liver Fibrosis | Not yet recruiting | Bezmialem Vakif University | 90 | 2025-04-10 | 2025-04-09 |
Showing 20 of 36. Sign in to see all of them.
Arthritis, Psoriatic (36) · Arthritis, Rheumatoid (15) · Psoriasis (6) · Spondylitis, Ankylosing (6) · Autoimmune Diseases (5) · Myositis (4) · Scleroderma, Systemic (4) · Arthritis, Juvenile (3) · Axial Spondyloarthritis (3) · Connective Tissue Diseases (3) · Giant Cell Arteritis (3) · Polymyalgia Rheumatica (3) · Rheumatic Diseases (3) · Spondylarthritis (3) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2)
Bone Diseases (36) · Musculoskeletal Diseases (36) · Skin Diseases, Papulosquamous (36) · Skin and Connective Tissue Diseases (36) · Spinal Diseases (36) · Spondylitis (36) · Joint Diseases (35) · Skin Diseases (35) · Spondylarthropathies (35) · Arthritis (34) · Spondylarthritis (33) · Psoriasis (30) · Immune System Diseases (17) · Connective Tissue Diseases (14) · Rheumatic Diseases (14)
Aspirin (1) · Biological Therapy (1) · Clopidogrel (1) · Community-Institutional Relations (1) · Critical Care (1) · Dietary Fiber (1) · Flow Cytometry (1) · Glucagon-Like Peptide-1 Receptor Agonists (1) · Injections (1) · Methotrexate (1) · Observation (1) · Polymorphism, Single Nucleotide (1) · Solutions (1) · Tirzepatide (1) · Ultrasonography, Carotid Arteries (1)
AbbVie (2) · Assistance Publique - Hôpitaux de Paris (2) · Bristol-Myers Squibb (2) · University of Bonn (2) · Adelphi Real World (1) · Ain Shams University (1) · Bezmialem Vakif University (1) · Brain Inflammation Collaborative (1) · Cairo University (1) · Charite University, Berlin, Germany (1) · Chinese University of Hong Kong (1) · Dr. Schär AG / SPA (1) · Forward Therapeutics (1) · Instituto de Investigación Marqués de Valdecilla (1) · Juan Ruano Ruiz (1)
United States (8) · Canada (4) · Germany (4) · Brazil (3) · France (3) · Greece (3) · Spain (3) · United Kingdom (3) · Australia (2) · China (2) · Denmark (2) · Egypt (2) · Italy (2) · Netherlands (2) · Portugal (2)
Ana Maria Rodrigues, MD, PhD (1) · Brent R Ohata, MD (1) · Carl Goodyear, PhD, (1) · Dina Ossama Abdulazim, assistant professor (1) · Francesca Ingegnoli, Professor (1) · Janet E. Pope, MD, MPH, FRCPC (1) · Jennifer Martin, MD (1) · Jette Primdahl, Professor (1) · Joseph F. Merola, MD MMSc (1) · Lyn Ferguson, MBChB, PhD, (1) · Megan L Fitzgerald, PhD (1)
PMID 23841941, PMID 34815219, PMID 35701011, PMID 35816681, PMID 36178584, PMID 36282537, PMID 38498139, PMID 38739215, PMID 39120849, PMID 40441347, PMID 41028616, PMID 41051639, PMID 41318485
2025 (2), 2023 (1), K23HL152013 (1)